M Feldmann

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy

Fionula M. Brennan, Kenneth A. Browne, P. A. Green et al. · Lara D. Veeken · 1997 · 180 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram

Susan Ross, Richard Williams, Lesley Mason et al. · The Journal of Immunology · 1997 · 113 citations · Full text

Medicine, Immunology, Pharmacology +17

Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease.

Gavin Giovannoni, John Thorpe, Desmond P. Kidd et al. · Journal of Neurology Neurosurgery & Psychiatry · 1996 · 66 citations · Full text

Life Sciences, Immunology, Neurology +14

Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease

Gavin Giovannoni, Nicholas Silver, J O’Riordan et al. · Multiple Sclerosis Journal · 1999 · 42 citations

Life Sciences, Immunology, Neurology +17

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.

M Feldmann, Fionula M. Brennan, Richard Williams et al. · PubMed · 1997 · 38 citations

Life Sciences, Immunology, Internal Medicine +16